Fundraising Fox

Thilo Schroeder

Investor

Partner at Nextech Invest

Zurich, Switzerland

Writes $100K – $5M checks · typically $1.5M

About

Oncology-focused investor who has been with Nextech since 2012, specializing in precision medicines and targeted therapies. Holds multiple current and past board seats at publicly traded and private biotech companies.

Experience

  1. Nextech Invest Ltd.Managing Partnercurrent2012 — presentZürich und Umgebung, Schweiz
  2. Synnovation TherapeuticsMember Board of Directorscurrent2023 — present
  3. Exo TherapeuticsBoard Membercurrent2021 — presentBoston, Massachusetts, United States
  4. Atavistik BioMember Board Of Directorscurrent2021 — present
  5. MOMA TherapeuticsBoard Membercurrent2020 — present
  6. Circle Pharma, Inc.Board Membercurrent2020 — present
  7. REVOLUTION MedicinesMember Board Of Directorscurrent2018 — presentRedwood City, CA, USA
  8. IDRxBoard Observer2022 — 2025
  9. Alterome Therapeutics, IncMember Board Of Directors2022 — 2024
  10. Mariana OncologyBoard Observer2023 — 2024
  11. CARGO TherapeuticsBoard Observer2023
  12. PMV Pharmaceuticals, Inc.Member Board Of Directors2019 — 2023
  13. Silverback TherapeuticsBoard Member2020 — 2022
  14. IDEAYA BiosciencesMember Board Of Directors2018 — 2020
  15. Black Diamond TherapeuticsBoard Observer2018 — 2020
  16. ImaginAbMember of the Board of Directors2016 — 2020Großraum Los Angeles und Umgebung
  17. Peloton TherapeuticsMember of the Board of Directors2014 — 2019Dallas/Fort Worth und Umgebung
  18. Blueprint MedicinesMember of the Board of Directors2014 — 2015Großraum Boston und Umgebung
  19. SiROP AssociationPresident2007 — 2013Zürich und Umgebung, Schweiz
  20. University of ZurichPHD Student2007 — 2012

Education

  1. University of ZurichPhD, Biochemistry; Structural biology and protein engineering
  2. ESBS2006, Biotechnology; Protein biochemistry2003 — 2006
  3. Klostergymnasium GroßkrotzenburgHigh school diploma
  4. Life Science Zurich Graduate School, ETH |Universityof the PhD Program, Molecular Life Science
  5. Technische Universität DarmstadtVordiplom, Biology; Molecular biology

Same school

Shared employers

Deals · 1

Revolution MedicinesBoard seat

via Nextech Invest · filed Jul 2018 · $56.4M raise

Attribution from SEC filings, press coverage, and firm rosters.

Colleagues at Nextech Invest

Network5

Investors connected to Thilo in public investor directories — a warm-intro map.